• 1
    Uribe M, Moran S, Poo JL, Mendez-Sanchez L, Guevara L, Garcia-Ramos G. Beneficial effect of carbohydrate maldigestion induced by disaccharidase inhibitor (AO-128) in the treatment of chronic portal systemic encephalopathy. Scan J Gastroenterol 1998; 33: 10991106.
  • 2
    Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998. HEPATOLOGY 2002; 35: 716721.
  • 3
    Blei AT, Cordoba J. Hepatic Encephalopathy. Am J Gastroenterol 2001; 96: 19681976.
    Direct Link:
  • 4
    Sanaka MR, Ong JP, Mullen KD. Challenges of designing hepatic encephalopathy treatment trials. HEPATOLOGY 2003: 38; 527528.